Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 49.89M | $ 47.66M | $ 2.23M |
3/31/2025 | $ 37.6M | $ 49.56M | $ -11.96M |
12/31/2024 | $ 51.69M | $ 45.8M | $ 5.89M |
9/30/2024 | $ 58.13M | $ 43.16M | $ 14.97M |
6/30/2024 | $ 40.08M | $ 39.01M | $ 1.07M |
3/31/2024 | $ 68.64M | $ 40.24M | $ 28.39M |
12/31/2023 | $ 94.33M | $ 47.73M | $ 46.6M |
9/30/2023 | $ 147.58M | $ 48.48M | $ 99.09M |
6/30/2023 | $ 159.61M | $ 53.79M | $ 105.82M |
3/31/2023 | $ 227.09M | $ 57.84M | $ 169.25M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for SANGAMO THERAPEUTICS INC is calculated as follows: AssetsC [ $ 700.29M ] - LiabilitesC [ $ 123.56M ]
(=) Working Capital [ $ 576.73M ]
Minimum
Mar 31, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -457.39M |
max | $ 607.04M |
average | $ 96.6M |
median | $ 32.21M |
std | $ 173.49M |